SCHEMBL30858862

SCHEMBL30858862

CC1(C)OB(c2cc(Cl)cc3c2cnn3C2CCCCO2)OC1(C)C

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ RXRG P48443 1/20 0.37
▸ CYP4F2 P78329 2/20 0.35
▸ CYP4A11 Q02928 2/20 0.35
▸ DGAT2 Q96PD7 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ PDE1A P54750 4/20 0.33
▸ PDE1B Q01064 4/20 0.33
▸ PDE1C Q14123 4/20 0.33
▸ RET P07949 1/20 0.33
▸ YTHDC1 Q96MU7 1/20 0.31
▸ ATR Q13535 2/20 0.31
▸ PDE9A O76083 1/20 0.31
▸ IDH1 O75874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20581028 1.00 RXRA (0.37) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL23043800 0.88 CYP4F2 (0.38) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30392077 0.88 CYP4F2 (0.38) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL31093701 0.87 CYP4F2 (0.37) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL31015405 0.85 PDE1B (0.36) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL30797632 0.84 CREBBP (0.35) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL27165299 0.84 RXRA (0.35) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL15229935 0.84 RXRA (0.35) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL29734718 0.84 RXRA (0.38) RXRARXRBRXRGCYP4F2CYP4A11
SCHEMBL26920565 0.84 RXRA (0.38) RXRARXRBRXRGCYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215156-B1 INHIBITORS OF TRYPTOPHAN-2,3-DIOXYGENASE OR INDOLEAMINE-2,3-DIOXYGENASE IOMET PHARMA LTD (GB) 2025-09-24 — — EP disclosed
EP-4581024-A1 SUBSTITUTED HETEROCYCLES AS RAS INHIBITORS Jazz Pharmaceuticals Ireland Limited (IE) 2025-07-09 — — EP disclosed
WO-2024047135-A1 SUBSTITUTED HETEROCYCLES AS RAS INHIBITORS JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2024-03-07 — — WO disclosed
Send feedback